- Home
- VTRS vs EDR Comparison
VTRS vs EDR Comparison
Compare VTRS & EDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTRS
- EDR
- Stock Information
- Founded
- VTRS 1961
- EDR 2009
- Country
- VTRS United States
- EDR United States
- Employees
- VTRS N/A
- EDR 10000
- Industry
- VTRS Medicinal Chemicals and Botanical Products
- EDR Services-Misc. Amusement & Recreation
- Sector
- VTRS Health Care
- EDR Consumer Discretionary
- Exchange
- VTRS Nasdaq
- EDR Nasdaq
- Market Cap
- VTRS 11.0B
- EDR 9.5B
- IPO Year
- VTRS N/A
- EDR 2021
- Fundamental
- Price
- VTRS $8.68
- EDR N/A
- Analyst Decision
- VTRS Hold
- EDR Hold
- Analyst Count
- VTRS 4
- EDR 8
- Target Price
- VTRS $10.50
- EDR $27.81
- AVG Volume (30 Days)
- VTRS 17.7M
- EDR 1.2M
- Earning Date
- VTRS 05-08-2025
- EDR 05-08-2025
- Dividend Yield
- VTRS 5.53%
- EDR 0.83%
- EPS Growth
- VTRS N/A
- EDR N/A
- EPS
- VTRS N/A
- EDR N/A
- Revenue
- VTRS $14,739,300,000.00
- EDR $7,110,982,000.00
- Revenue This Year
- VTRS N/A
- EDR N/A
- Revenue Next Year
- VTRS $0.99
- EDR $15.54
- P/E Ratio
- VTRS N/A
- EDR N/A
- Revenue Growth
- VTRS N/A
- EDR 29.51
- 52 Week Low
- VTRS $8.62
- EDR $24.41
- 52 Week High
- VTRS $13.55
- EDR $35.99
- Technical
- Relative Strength Index (RSI)
- VTRS 29.72
- EDR 6.47
- Support Level
- VTRS $9.01
- EDR $28.56
- Resistance Level
- VTRS $9.35
- EDR $29.60
- Average True Range (ATR)
- VTRS 0.27
- EDR 0.32
- MACD
- VTRS 0.00
- EDR -3.31
- Stochastic Oscillator
- VTRS 5.56
- EDR 0.00
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
About EDR Endeavor Group Holdings Inc.
Endeavor Group Holdings Inc is an entertainment and sports company. The company owns and operates sports and entertainment properties, including UFC and WWE through its majority ownership of TKO, produces and distributes sports and entertainment content, owns and manages exclusive live events and experiences, and represents top sports, entertainment, and fashion talent, as well as blue chip corporate clients. Its reportable segments are Owned Sports Properties, Events, Experiences & Rights, and Representation. Maximum revenue is generated from its Owned Sports Properties segment, which is comprised of a portfolio of sports and entertainment properties, including UFC, WWE, PBR, and Euroleague. Geographically, it derives key revenue from the United States.